0001104659-24-002371.txt : 20240108 0001104659-24-002371.hdr.sgml : 20240108 20240108210633 ACCESSION NUMBER: 0001104659-24-002371 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240104 FILED AS OF DATE: 20240108 DATE AS OF CHANGE: 20240108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ashar Bhavesh CENTRAL INDEX KEY: 0001849740 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39044 FILM NUMBER: 24521565 MAIL ADDRESS: STREET 1: C/O SPRINGWORKS THERAPEUTICS STREET 2: 100 WASHINGTON BLVD CITY: STAMFORD STATE: CT ZIP: 05902 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SpringWorks Therapeutics, Inc. CENTRAL INDEX KEY: 0001773427 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 WASHINGTON BOULEVARD CITY: STAMFORD STATE: CT ZIP: 06902 BUSINESS PHONE: 203-883-9490 MAIL ADDRESS: STREET 1: 100 WASHINGTON BOULEVARD CITY: STAMFORD STATE: CT ZIP: 06902 4 1 tm242462-1_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-01-04 0 0001773427 SpringWorks Therapeutics, Inc. SWTX 0001849740 Ashar Bhavesh C/O SPRINGWORKS THERAPEUTICS, INC. 100 WASHINGTON BLVD. STAMFORD CT 06902 0 1 0 0 Chief Commercial Officer 0 Common Stock 2024-01-04 4 A 0 26445 0.00 A 70166 D Common Stock 2024-01-05 4 F 0 2507 37.96 D 67659 D Common Stock 2024-01-08 4 F 0 1449 41.53 D 66210 D Stock Option (Right to Buy) 38.40 2024-01-04 4 A 0 75000 0 A 2034-01-03 Common Stock 75000 75000 D This transaction represents a grant of restricted stock units ("RSUs"). The RSUs shall vest as follows: thirty-three percent (33%) to vest on January 4, 2025, another thirty-three percent (33%) to vest on January 4, 2026 and the remaining thirty-four percent (34%) to vest on January 4, 2027, subject to continued service to the Issuer by the Reporting Person through each applicable vesting date. Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs and does not represent a sale by the Reporting Person. This option shall vest in forty-eight (48) equal monthly installments following January 4, 2024, subject to continued service to the Issuer by the Reporting Person through each applicable vesting date. /s/ Francis I. Perier, Jr. as Attorney-in Fact 2024-01-08